Persistent potential adverse reactions associated with paliperidone palmitate included weight gain, elevated prolactin levels, psychotic disorders, galactorrhea, amenorrhea, akathisia, extrapyramidal disorders, suicidal ideation, hyperprolactinemia, and erectile dysfunction (Table S3). This evidence concerns the gene PRL and hyperprolactinemia.